CA2685737A1 - Methods and compositions for the treatment of cancer - Google Patents

Methods and compositions for the treatment of cancer Download PDF

Info

Publication number
CA2685737A1
CA2685737A1 CA002685737A CA2685737A CA2685737A1 CA 2685737 A1 CA2685737 A1 CA 2685737A1 CA 002685737 A CA002685737 A CA 002685737A CA 2685737 A CA2685737 A CA 2685737A CA 2685737 A1 CA2685737 A1 CA 2685737A1
Authority
CA
Canada
Prior art keywords
seq
mesd
oligopeptide
lrp6
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002685737A
Other languages
English (en)
French (fr)
Inventor
Guojun Bu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Washington University in St. Louis
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2685737A1 publication Critical patent/CA2685737A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002685737A 2007-04-30 2008-04-30 Methods and compositions for the treatment of cancer Abandoned CA2685737A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91490207P 2007-04-30 2007-04-30
US60/914,902 2007-04-30
PCT/US2008/062092 WO2008134752A2 (en) 2007-04-30 2008-04-30 Methods and compositions for the treatment of cancer

Publications (1)

Publication Number Publication Date
CA2685737A1 true CA2685737A1 (en) 2008-11-06

Family

ID=39926323

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002685737A Abandoned CA2685737A1 (en) 2007-04-30 2008-04-30 Methods and compositions for the treatment of cancer

Country Status (7)

Country Link
US (1) US8198236B2 (enExample)
EP (1) EP2150270A4 (enExample)
JP (1) JP2010526090A (enExample)
AU (1) AU2008245425A1 (enExample)
BR (1) BRPI0810207A2 (enExample)
CA (1) CA2685737A1 (enExample)
WO (1) WO2008134752A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080227698A1 (en) * 2005-11-08 2008-09-18 Washington University Oligopeptides for treatment of osteoporosis and other bone diseases and methods thereof
KR20120117621A (ko) * 2009-05-07 2012-10-24 노파르티스 아게 딕코프－１ 또는 딕코프－４ 또는 둘 모두에 대한 결합 분자에 대한 조성물 및 사용 방법
SG185416A1 (en) * 2010-05-06 2012-12-28 Novartis Ag Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies
US8883735B2 (en) 2011-11-04 2014-11-11 Novartis Ag Low density lipoprotein-related protein 6 (LRP6)-half life extender constructs
US9493528B2 (en) 2013-01-10 2016-11-15 Supadelixir Inc. Microphthalmia-associated transcription factor-derived peptide and composition containing same
EP3265112B1 (en) * 2015-01-19 2025-12-24 Technion Research & Development Foundation Limited Ubiquitin ligase kpc1 and p50 for use in the treatment of cancer
KR102073144B1 (ko) * 2018-12-13 2020-02-04 주식회사 엘베이스 올리고펩티드를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물
CN114853847B (zh) 2022-06-29 2022-09-27 中国农业大学 辣椒籽分离的寡肽ftle及其在预防或治疗癌症中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036440A1 (en) * 1999-11-19 2001-05-25 Human Genome Sciences, Inc. 23 human secreted proteins
US20030082767A1 (en) * 1997-09-18 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US8637506B2 (en) * 2003-09-22 2014-01-28 Enzo Biochem, Inc. Compositions and methods for bone formation and remodeling
US9062126B2 (en) * 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
US20080227698A1 (en) * 2005-11-08 2008-09-18 Washington University Oligopeptides for treatment of osteoporosis and other bone diseases and methods thereof

Also Published As

Publication number Publication date
AU2008245425A2 (en) 2010-01-07
JP2010526090A (ja) 2010-07-29
US20100120685A1 (en) 2010-05-13
AU2008245425A1 (en) 2008-11-06
WO2008134752A2 (en) 2008-11-06
BRPI0810207A2 (pt) 2014-10-14
WO2008134752A3 (en) 2008-12-24
US8198236B2 (en) 2012-06-12
EP2150270A2 (en) 2010-02-10
EP2150270A4 (en) 2011-09-28

Similar Documents

Publication Publication Date Title
AU2008245425A1 (en) Methods and compositions for the treatment of cancer
EP3260130B1 (en) Methods for treating fatty liver disease
CN102482339B (zh) 用于增加产热脂肪细胞的方法
US8293238B2 (en) GDF3 antibodies and related methods
JP2003525595A (ja) 脈管形成に含まれる差動発現遺伝子、それにコードされるポリペプチド、及びそれを用いた方法
CA2331332A1 (en) Anti-angiogenic proteins and methods of use thereof
US20070059829A1 (en) Cristin/R-spondin ligands active in the Wnt signaling pathway and methods, compositions and kits relating thereto
US20080226556A1 (en) Removal promoters and inhibitor for apoptosis cells in vivo
US7557083B2 (en) Gastrokines and derived peptides including inhibitors
Xu et al. Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells
CN100485035C (zh) 新型清除蛋白受体
US6759047B1 (en) Anti-angiogenic proteins and methods of use thereof
AU766098B2 (en) Thrombospondin-2 and uses thereof
US20080227698A1 (en) Oligopeptides for treatment of osteoporosis and other bone diseases and methods thereof
Stewart Biochemical and Physiological Characterization of Secreted Proteins Regulating Whole-body Energy Homeostasis
Greene Syndecan-4 associates with α-actinin and its role in cell adhesion
Chen The role of syndecan-2 in matrix deposition
HK1228323B (en) Bmp-alk3 antagonists and uses for promoting bone growth

Legal Events

Date Code Title Description
EEER Examination request
EEER Examination request

Effective date: 20121206

FZDE Dead

Effective date: 20140430